Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Aug;69(2):236–238. doi: 10.1136/adc.69.2.236

Immunoadsorption plasmapheresis for severe generalised myasthenia gravis.

M Ichikawa 1, C S Koh 1, Y Hata 1, M Tohyama 1, T Tsuno 1, A Komiyama 1
PMCID: PMC1029466  PMID: 8215529

Abstract

Two patients with severe generalised myasthenia gravis of childhood were successfully treated with immunoadsorption plasmapheresis. One patient was a 5 year old girl and the other was a 12 year old girl. A dramatic improvement in bulbar symptoms and generalised muscle weakness was achieved without any side effects. Plasma exchange may also yield clinical improvement for myasthenia gravis, but the treatment is accompanied by the risk of viral infections and hypersensitivity reactions. Immunoadsorption plasmapheresis is an effective treatment for severe generalised myasthenia gravis of childhood and is superior to plasma exchange with respect to safety.

Full text

PDF
236

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Batocchi A. P., Evoli A., Palmisani M. T., Lo Monaco M., Bartoccioni M., Tonali P. Early-onset myasthenia gravis: clinical characteristics and response to therapy. Eur J Pediatr. 1990 Nov;150(1):66–68. doi: 10.1007/BF01959485. [DOI] [PubMed] [Google Scholar]
  2. Drachman D. B. Myasthenia gravis (first of two parts). N Engl J Med. 1978 Jan 19;298(3):136–142. doi: 10.1056/NEJM197801192980305. [DOI] [PubMed] [Google Scholar]
  3. Drachman D. B. Myasthenia gravis (second of two parts). N Engl J Med. 1978 Jan 26;298(4):186–193. doi: 10.1056/NEJM197801262980404. [DOI] [PubMed] [Google Scholar]
  4. Evoli A., Batocchi A. P., Palmisani M. T., Lo Monaco M., Tonali P. Long-term results of corticosteroid therapy in patients with myasthenia gravis. Eur Neurol. 1992;32(1):37–43. doi: 10.1159/000116785. [DOI] [PubMed] [Google Scholar]
  5. Hosokawa S., Oyamaguchi A. Safety, stability, and effectiveness of immunoadsorption under membrane plasmapheresis treatment for myasthenia gravis. ASAIO Trans. 1990 Jul-Sep;36(3):M207–M208. [PubMed] [Google Scholar]
  6. Keys P. A., Blume R. P. Therapeutic strategies for myasthenia gravis. DICP. 1991 Oct;25(10):1101–1108. doi: 10.1177/106002809102501016. [DOI] [PubMed] [Google Scholar]
  7. Passalacqua S., Splendiani G., Sturniolo A., Costanzi S., Barbera G., Bartoccioni E., Evoli A., Scoppetta C., Adorno D., Di Guilio S. Immunosorbent treatment in myasthenia gravis. Prog Clin Biol Res. 1990;337:285–288. [PubMed] [Google Scholar]
  8. Pinching A. J., Peters D. K. Remission of myasthenia gravis following plasma-exchange. Lancet. 1976 Dec 25;2(8000):1373–1376. doi: 10.1016/s0140-6736(76)91917-6. [DOI] [PubMed] [Google Scholar]
  9. Roach E. S., Buono G., McLean W. T., Jr, Weaver R. G., Jr Early-onset myasthenia gravis. J Pediatr. 1986 Feb;108(2):193–197. doi: 10.1016/s0022-3476(86)80981-7. [DOI] [PubMed] [Google Scholar]
  10. Sakano T., Hamasaki T., Kinoshita Y., Kihara M., Ueda K. Treatment for refractory myasthenia gravis. Arch Dis Child. 1989 Aug;64(8):1191–1193. doi: 10.1136/adc.64.8.1191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sato T., Ishigaki Y., Komiya T., Tsuda H. Therapeutic immunoadsorption of acetylcholine receptor antibodies in myasthenia gravis. Ann N Y Acad Sci. 1988;540:554–556. doi: 10.1111/j.1749-6632.1988.tb27170.x. [DOI] [PubMed] [Google Scholar]
  12. Seybold M. E. Myasthenia gravis. A clinical and basic science review. JAMA. 1983 Nov 11;250(18):2516–2521. doi: 10.1001/jama.250.18.2516. [DOI] [PubMed] [Google Scholar]
  13. Snead O. C., 3rd, Kohaut E. C., Oh S. J., Bradley R. J. Plasmapheresis for myasthenic crisis in a young child. J Pediatr. 1987 May;110(5):740–742. doi: 10.1016/s0022-3476(87)80014-8. [DOI] [PubMed] [Google Scholar]
  14. Splendiani G., Passalacqua S., Barbera G., Sturniolo A., Costanzi S., Bartoccioni E., Casciani C. U. Myasthenia gravis (MG) treatment with immunoadsorbent columns. Biomater Artif Cells Immobilization Biotechnol. 1991;19(1):255–265. doi: 10.3109/10731199109117831. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES